Avaliação Integrada da Sobrevivência, Conversão Cirúrgica e Toxicidade para Terapia de Indução em Metástases Colorectais Inicialmente Insectáveis: Uma Meta-análise Individual da Rede de Dados do Paciente
GastroenterologiaSobre o estudo
- Desenho
- Estudo
- Nível de evidência
- 2 · Nova evidência
- Revista
- Annals of surgical oncology
- Publicado em
- 16 jul 2026
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Integrated Evaluation of Survival, Surgical Conversion, and Toxicity for Induction Therapy in Initially Unresectable Colorectal Liver Metastases: An Individual Patient Data Network Meta-analysis
Guilin Nie, Xinming Li, Yaoqun Wang, Jianrong Xu, Ningyuan Wen, Bei Li, Jiong Lu
Descritores MeSH
- Hepatectomy
- Colorectal Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Liver Neoplasms
- Induction Chemotherapy
- Prognosis
- Humans
- Bevacizumab
- Survival Rate
- Randomized Controlled Trials as Topic
Veja também
Estudos relacionados
- Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Phase II Study: SULTAN UCGI 30/PRODIGE 53 (NCT03164655)
- Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial
- TAS-102 plus bevacizumab versus TAS-102 alone for metastatic colorectal cancer: a systematic review and meta-analysis
- Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis
- Targeted therapy in advanced BRAF-mutated colorectal cancer: systematic review and network meta-analysis
- Evaluation of the efficacy and safety of first- and second-line immunotherapy in patients with metastatic colorectal cancer: a systematic review and network meta-analysis based on randomized controlled trials